PAPER Rigaud AS, Traykov L, Caputo L, Coste J, Latour F, Couderc R, Moulin F, Boller F, Forette F

Association of the apolipoprotein E epsilon4 allele with late-onset depression.

Neuroepidemiology. 2001 Oct;20(4):268-72. PubMed.

PAPER Reid RT, Sabbagh MN, Thal LJ

Does apolipoprotein E (Apo-E) genotype influence nicotinic receptor binding in Alzheimer's disease.

J Neural Transm. 2001 Sep;108(8-9):1043-50. PubMed.

PAPER Robinson-Agramonte MA, Grazia De Simoni M, Serrano-Sánchez T, Llibre JJ, Hernández E

[Circulating cytokines in Alzheimer's disease].

Rev Neurol. 2001 Jul 1-15;33(1):99-100. PubMed.

PAPER Amatore C, Arbault S, Bruce D, de Oliveira P, Erard LM, Vuillaume M

Characterization of the electrochemical oxidation of peroxynitrite: relevance to oxidative stress bursts measured at the single cell level.

Chemistry. 2001 Oct 1;7(19):4171-9. PubMed.

PAPER Lacritz LH, Cullum CM, Weiner MF, Rosenberg RN

Comparison of the hopkins verbal learning test-revised to the California verbal learning test in Alzheimer's disease.

Appl Neuropsychol. 2001;8(3):180-4. PubMed.

PAPER Scott HD, Laake K

Statins for the reduction of risk of Alzheimer's disease.

Cochrane Database Syst Rev. 2001;(3):CD003160. PubMed.

PAPER Olin J, Schneider L

Galantamine for Alzheimer's disease.

Cochrane Database Syst Rev. 2001;(4):CD001747. PubMed.

PAPER Lonergan E, Luxenberg J, Colford J

Haloperidol for agitation in dementia.

Cochrane Database Syst Rev. 2001;(4):CD002852. PubMed.

PAPER Fioravanti M, Flicker L

Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.

Cochrane Database Syst Rev. 2001;(4):CD003159. PubMed.

PAPER Scott HD, Laake K

Statins for the prevention of Alzheimer's disease.

Cochrane Database Syst Rev. 2001;(4):CD003160. PubMed.

PAPER Ghisla MK, Marengoni A, Cossi S, Leonardi R

[Cognitive deficiency in internal medicine].

Ann Ital Med Int. 2001 Apr-Jun;16(2):106-11. PubMed.

PAPER Rampa A, Piazzi L, Belluti F, Gobbi S, Bisi A, Bartolini M, Andrisano V, Cavrini V, Cavalli A, Recanatini M, Valenti P

Acetylcholinesterase inhibitors: SAR and kinetic studies on omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl derivatives.

J Med Chem. 2001 Nov 8;44(23):3810-20. PubMed.

PAPER Yasojima K, McGeer EG, McGeer PL

Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain.

Brain Res. 2001 Nov 16;919(1):115-21. PubMed.

PAPER Pike CJ

Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons.

Brain Res. 2001 Nov 16;919(1):160-5. PubMed.

PAPER Herrup K, Yang Y

Pictures in molecular medicine: contemplating Alzheimer's disease as cancer: a loss of cell-cycle control.

Trends Mol Med. 2001 Nov;7(11):527. PubMed.